platinum has been researched along with Endometrial Neoplasms in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (14.29) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 9 (32.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bignotti, E; Bugatti, M; Calza, S; Capoferri, D; Lonardi, S; Odicino, F; Pijnenborg, JMA; Ratti, M; Ravaggi, A; Reijnen, C; Romani, C; Sartori, E; Tognon, G; Zanotti, L | 1 |
| Karl, F; Krenzer, S; Link, T; Maywald, U; Mevius, A; Wacker, M; Welte, R; Wilke, T | 1 |
| Bartoletti, M; Canzonieri, V; Clemente, N; Corsetti, S; Fornasarig, M; Giorda, G; Lucia, E; Nicoloso, MS; Palazzari, E; Pivetta, T; Puglisi, F; Scalone, S; Segatto, E; Sorio, R; Viel, A; Zdjelar, A | 1 |
| Alexandre, J; Brachet, PE; Colomba, E; Coquard, IR; Coupez, D; de Percin, S; Delanoy, N; Fabbro, M; Frenel, JS; Genestie, C; Joly, F; Le Teuff, G; Leary, A; Pautier, P; Sajous, C | 1 |
| Allonby, O; Boyne, DJ; Brenner, DR; Cheung, WY; Habash, M; Martins, D; McGee, J; O'Sullivan, DE; Riemer, J | 1 |
| Asanoma, K; Hachisuga, K; Hori, E; Kato, K; Kodama, K; Maenohara, S; Ohgami, T; Okugawa, K; Onoyama, I; Yagi, H; Yahata, H; Yasunaga, M | 1 |
| Goulden, S; Heffernan, K; Hunger, M; Knott, C; Pahwa, A; Schade, R; Sen Nikitas, F; Shukla, U | 1 |
| Angeli, E; Boudier, P; de la Motte Rouge, T; Delanoy, N; Eberst, L; El Mouaddin, N; Fiteni, F; Flippot, R; Follana, P; Gauthier, L; Jacquemin, V; Roche, S; Rodrigues, M; Sabatier, R; Tessier, C | 1 |
| Backes, FJ; Bixel, KL; Chambers, LM; Cohn, DE; Copeland, LJ; Cosgrove, CM; Haight, PJ; Khadraoui, W; Kistenfeger, Q; Nagel, CI; O'Malley, DM; Riedinger, CJ; Spakowicz, DJ | 1 |
| Cantrell, LA; Duska, LR; Garcia, C; Montemorano, L; Saks, E | 1 |
| Cosio, S; Fabrini, MG; Gadducci, A; Laliscia, C; Mazzotti, V; Morganti, R; Paiar, F | 1 |
| Liu, LH; Liu, YH; Xu, L; Yang, H | 1 |
| Bielawska, A; Bielawski, K; Czarnomysy, R; Muszyńska, A | 1 |
| Angioli, R; De Felice, F; Giorgini, M; Iadarola, R; Lecce, F; Marchetti, C; Monti, M; Musella, A; Muzii, L; Palaia, I; Panici, PB; Perniola, G; Vertechy, L | 1 |
| Achatz, MI; Baiocchi, G; da Costa, AA; Guimarães, AP; Mantoan, H; Saito, A; Sanches, S; Valadares, CV | 1 |
| Abiko, K; Baba, T; Chikuma, S; Hamanishi, J; Honjo, T; Hosoe, Y; Ikeda, T; Kanai, M; Kawaguchi, A; Konishi, I; Mandai, M; Matsumoto, S; Matsumura, N; Minami, M; Mori, Y; Morita, S; Murayama, T; Shimizu, A; Ueda, A; Yamaguchi, K; Yokode, M | 1 |
| Cianci, S; Costantini, B; De Iaco, P; Fagotti, A; Perrone, M; Petrillo, M; Ronsini, C; Scambia, G | 1 |
| Ansari, J; Buckley, L; Fernando, I; Tanguay, JS | 1 |
| Fujitoh, A; Isaka, K; Ito, H; Nishi, H; Sagawa, Y; Yudate, T | 1 |
| Boren, TP; Miller, DS | 1 |
| Bertoni, F; Catapano, CV; Colombo, N; Del Conte, G; Gadducci, A; Hess, D; Katsaros, D; Mancari, R; Marsoni, S; Parma, G; Rinaldi, A; Scambia, G; Sessa, C; van de Velde, H; Vitali, A | 1 |
| Agarwal, R; Blagden, S; Diamantis, N; Gabra, H; Shaboodien, R | 1 |
| Cormio, G; Cuccovillo, A; Fattizzi, N; Loizzi, V; Selvaggi, L | 1 |
| Angioli, R; Basile, S; Bellati, F; Benedetti Panici, P; De Vivo, A; Manci, N; Muzii, L; Perniola, G | 1 |
| Chen, JT; Hasumi, K | 1 |
| Beller, U; Diamant, Y; Lavie, O; Neuman, M; Rosemann, E | 1 |
| Hattori, S; Inoue, T; Ishikawa, H; Kikkawa, F; Matsuzawa, K; Suganuma, N; Tamakoshi, K; Tokuhashi, Y; Tomoda, Y | 1 |
| Belinson, J; Kennedy, A; Kulp, B; Markman, M; Peterson, G; Webster, K | 1 |
2 review(s) available for platinum and Endometrial Neoplasms
| Article | Year |
|---|---|
Two cases of endometrial cancer diagnosis associated with bone metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Cervical Vertebrae; Cyclophosphamide; Diphosphonates; Doxorubicin; Endometrial Neoplasms; Fatal Outcome; Female; Humans; Imidazoles; Middle Aged; Platinum; Spinal Neoplasms; Tibia; Zoledronic Acid | 2006 |
Serous papillary adenocarcinoma of the endometrium. A unique entity with a grave prognosis. Case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Ovariectomy; Platinum; Prognosis | 1993 |
4 trial(s) available for platinum and Endometrial Neoplasms
| Article | Year |
|---|---|
Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Topics: Adenocarcinoma, Clear Cell; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Cohort Studies; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Nivolumab; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Prognosis; Programmed Cell Death 1 Receptor; Salvage Therapy; Survival Rate | 2015 |
An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; CA-125 Antigen; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Pyrazines; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult | 2012 |
[Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carboplatin; Cisplatin; Creatinine; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Infusions, Intravenous; Platinum; Uterine Neoplasms | 1995 |
22 other study(ies) available for platinum and Endometrial Neoplasms
| Article | Year |
|---|---|
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.
Topics: Biomarkers, Tumor; Carboplatin; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Neoplasm Staging; Neural Cell Adhesion Molecule L1; Platinum; Prognosis | 2022 |
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Data Analysis; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies | 2023 |
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
Topics: Antibodies, Monoclonal, Humanized; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Platinum; Programmed Cell Death 1 Receptor | 2022 |
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Topics: Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Microsatellite Instability; Platinum; Retrospective Studies | 2023 |
Understanding Characteristics, Treatment Patterns, and Clinical Outcomes for Individuals with Advanced or Recurrent Endometrial Cancer in Alberta, Canada: A Retrospective, Population-Based Cohort Study.
Topics: Alberta; Cohort Studies; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies | 2023 |
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval.
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Platinum; Retrospective Studies | 2023 |
Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England.
Topics: Antibodies, Monoclonal, Humanized; Endometrial Neoplasms; Female; Humans; Platinum; Progression-Free Survival | 2023 |
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France.
Topics: Antibodies, Monoclonal, Humanized; Chronic Disease; Clinical Trials as Topic; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Microsatellite Instability; Platinum; Prospective Studies | 2023 |
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Topics: Anti-Bacterial Agents; Chemotherapy, Adjuvant; Cohort Studies; Endometrial Neoplasms; Female; Humans; Neoplasm Staging; Platinum; Proton Pump Inhibitors; Retrospective Studies | 2023 |
Cutting costs and standardizing care: Once-per-cycle complete blood count monitoring may be safe for patients undergoing platinum-based chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Chemotherapy-Induced Febrile Neutropenia; Endometrial Neoplasms; Female; Hospitalization; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Retrospective Studies | 2017 |
Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Platinum; Retrospective Studies; Survival Analysis; Treatment Failure | 2019 |
Efficacy of permanent iodine-125 seed implants and gemcitabine chemotherapy in patients with platinum- resistant recurrent ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Brachytherapy; Chemoradiotherapy; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Gemcitabine; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Prognosis; Tomography, X-Ray Computed | 2014 |
Effects of novel alkyl pyridine platinum complexes on apoptosis in Ishikawa endometrial cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Fibroblasts; Humans; Molecular Structure; Organoplatinum Compounds; Platinum; Pyridines; Structure-Activity Relationship | 2015 |
Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Chemotherapy, Adjuvant; Combined Modality Therapy; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 2015 |
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Combined Modality Therapy; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Injections, Intraperitoneal; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2016 |
Epithelial ovarian cancer: role of pegylated liposomal Doxorubicin in prolonging the platinum-free interval and cancer antigen 125 trends during treatment.
Topics: CA-125 Antigen; Carcinoma, Papillary; Cohort Studies; Cystadenocarcinoma, Serous; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2009 |
Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Mitomycin; Neoplasm Invasiveness; Platinum | 2011 |
Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Taxoids | 2010 |
Feasibility of trials in ovarian cancer by line of therapy and platinum sensitivity.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Endometrial Neoplasms; Feasibility Studies; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Patient Selection; Platinum; Prognosis; Survival Rate | 2013 |
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Observation; Ovarian Neoplasms; Platinum; Prognosis; Prospective Studies | 2007 |
Distribution of platinum in human gynecologic tissues and pelvic lymph nodes after administration of cisplatin.
Topics: Adult; Aged; Antineoplastic Agents; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Humans; Hysterectomy; Infusions, Intravenous; Lymph Node Excision; Lymph Nodes; Middle Aged; Myometrium; Ovary; Platinum; Spectrophotometry, Atomic; Treatment Outcome; Uterine Cervical Neoplasms | 1997 |
Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Platinum; Remission Induction | 1999 |